Vaccination & Treatment Intel
Active medical countermeasures for Ebola virus lineages include single-dose immunization vectors and monoclonal antibodies. While approved protocols like Ervebo (rVSV-ZEBOV) offer defense against the Zaire strain, the 2026 outbreak of the **Bundibugyo ebolavirus strain** currently relies on experimental clinical trials and broad-spectrum antivirals due to structural variation.
Approved Vaccines
Ervebo (rVSV-ZEBOV)
A single-dose live-attenuated vaccine. Highly effective against Zaire ebolavirus. Deployed primarily using a "ring vaccination" strategy around confirmed contacts.
Zabdeno & Mvabea
A two-dose prophylactic regimen. The second dose is administered 8 weeks after the first. Ideal for preventative protection in at-risk border corridors.
Active Therapeutics
Inmazeb (REGN-EB3)
A mixture of three monoclonal antibodies (atoltivimab, maftivimab, and odesivimab-ebgn). Administered intravenously, significantly reducing mortality when delivered early.
Ebanga (Ansuvimab)
A single monoclonal antibody that binds to the viral glycoprotein, blocking cellular entry. Sourced from a human survivor of historical outbreaks.
Clinical Investigations
mRNA Multi-Strain Modalities
Leveraging lipid nanoparticle mRNA delivery systems to produce multi-strain immunity models (targeting Zaire, Sudan, and Bundibugyo strains simultaneously).
Broad-Spectrum Antivirals
Investigating alternative oral polymerases designed to inhibit transcription mechanics without requiring complex cold-chain storage solutions.
Latest Vaccine & Treatment News
Ebola Outbreak Escalates in Democratic Republic of the Congo and Uganda: An Urgent Global Health Challenge
A significant Ebola outbreak involving the Bundibugyo virus strain, which currently lacks effective vaccines or treatments, is spreading in the Democratic Republic of the Congo and Uganda, prompting a rapid response from the WHO amidst challenging political and demographic conditions.
Global Health Emergency: WHO Declares Outbreak of Ebola's Bundibugyo Strain in 2026
The World Health Organization (WHO) has declared a Public Health Emergency of International Concern due to the rapidly spreading Ebola outbreak in the Democratic Republic of the Congo and Uganda, driven by the Bundibugyo strain.
Ebola Outbreak in DRC: A New Challenge Amid Ongoing Crisis
The Democratic Republic of Congo (DRC) is battling a devastating Ebola outbreak caused by the rare Bundibugyo virus. As cases rise and deaths mount, the world faces a daunting challenge with limited tools available for control.
Escalating Ebola Crisis in the Democratic Republic of Congo: Global Concerns Rise
A ferocious Ebola outbreak in the Democratic Republic of Congo has claimed over 200 lives, with health concerns rising as the virus spreads to neighboring Uganda. The World Health Organization warns of a high risk of rapid spread, highlighting the complicated response due to armed conflict, community distrust, and U.S. aid cuts.
Strict Medical Disclaimer
Ebola.ai is an automated public health data aggregate and intelligence platform utilizing real-time digital surveillance systems. Content published here is for geopolitical mapping, tracking, and information extraction purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always consult official directives from the World Health Organization (WHO), local Ministries of Health, or your primary healthcare provider for actionable clinical guidelines.